Literature DB >> 3027659

Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis.

K L Nakamaye, F Eckstein.   

Abstract

M13 RF IV DNA where phosphorothioate groups are incorporated at restriction endonuclease Nci I recognition sites in the (-)strand is efficiently nicked by the action of this enzyme. Incubation of such nicked DNA with exonuclease III produces gapped DNA. The gap can be filled by reaction with deoxynucleoside triphosphates and DNA polymerase I. When this sequence of reactions is performed with DNA containing a mismatch oligonucleotide primer in the (-)-strand mutational frequencies of 70-90% can be obtained upon transformation. The general nature of this methodology has been further shown to be applicable to other restriction enzymes such as Hind II, Pst I and Fsp I. The mutational frequency obtained using these enzymes is between 40-80% mainly because of less efficient nicking and gapping. Studies on inhibition of Nci I cleavage show that in addition to a phosphorothioate group at the position of cleavage an additional group in the 5'-neighbouring position is necessary for complete inhibition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027659      PMCID: PMC341328          DOI: 10.1093/nar/14.24.9679

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  13 in total

1.  Synchronous digestion of SV40 DNA by exonuclease III.

Authors:  R Wu; G Ruben; B Siegel; E Jay; P Spielman; C P Tu
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

2.  The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA.

Authors:  J W Taylor; W Schmidt; R Cosstick; A Okruszek; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

3.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

Review 4.  Site-directed mutagenesis.

Authors:  P Carter
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Sequence analysis of ultraviolet-induced mutations in M13lacZ hybrid phage DNA.

Authors:  J E LeClerc; N L Istock; B R Saran; R Allen
Journal:  J Mol Biol       Date:  1984-12-05       Impact factor: 5.469

8.  Construction of viable and lethal mutations in the origin of bacteriophage 'phi' X174 using synthetic oligodeoxyribonucleotides.

Authors:  P D Baas; W R Teertstra; A D van Mansfeld; H S Jansz; G A van der Marel; G H Veeneman; J H van Boom
Journal:  J Mol Biol       Date:  1981-11-15       Impact factor: 5.469

9.  Exonuclease III: use for DNA sequence analysis and in specific deletions of nucleotides.

Authors:  L H Guo; R Wu
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

10.  Sensitivity of Escherichia coli to viral nucleic acid. 8. Idiosyncrasy of Ca2+-dependent competence for DNA.

Authors:  A Taketo
Journal:  J Biochem       Date:  1974-04       Impact factor: 3.387

View more
  159 in total

1.  PNPase autocontrols its expression by degrading a double-stranded structure in the pnp mRNA leader.

Authors:  A C Jarrige; N Mathy; C Portier
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.

Authors:  A Hemming; A Bolmstedt; P Flodby; L Lundberg; M Gidlund; H Wigzell; S Olofsson
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase.

Authors:  S T Dobbs; P M Cullis; A Maxwell
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

4.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins.

Authors:  M T Bihoreau; V Baudin; M Marden; N Lacaze; B Bohn; J Kister; O Schaad; A Dumoulin; S J Edelstein; C Poyart
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

6.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Deletion of internal sequence on the HDV-ribozyme: elucidation of functionally important single-stranded loop regions.

Authors:  Y A Suh; P K Kumar; F Nishikawa; E Kayano; S Nakai; O Odai; S Uesugi; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

8.  Site-directed mutagenesis of the codon for Ile-25 in gPr80env alters the neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB.

Authors:  P F Szurek; E Floyd; P H Yuen; P K Wong
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Authors:  D C Scherer; J A Brockman; Z Chen; T Maniatis; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes.

Authors:  J M Shipley; M Klinkenberg; B M Wu; D R Bachinsky; J H Grubb; W S Sly
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.